GO:0046488 phosphatidylinositol metabolic process: Lipid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0046488 phosphatidylinositol metabolic process describes the chemical reactions and pathways involving phosphatidylinositol, a glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol.
• Phosphatidylinositol and its phosphorylated derivatives (phosphoinositides) are central to membrane trafficking, signal transduction, and nuclear lipid signaling.
• The pathway is controlled by a balance of kinases and phosphatases, including myotubularin phosphatases that specifically remove 3-phosphate groups from phosphoinositides.
• Dysregulation of phosphatidylinositol metabolism is linked to cancer, immune disorders, and neurological diseases.
• Phosphoinositides regulate STING activation and cholesterol homeostasis, connecting lipid metabolism to innate immunity.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting gene function in this pathway.
Description
Phosphatidylinositol (PtdIns) is a minor but critically important membrane phospholipid that serves as a precursor for a family of signaling molecules known as phosphoinositides. The Gene Ontology term GO:0046488, phosphatidylinositol metabolic process, encompasses all chemical reactions and pathways involving phosphatidylinositol, defined as any glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. This process is fundamental to eukaryotic cell biology, influencing membrane identity, vesicle trafficking, and signal transduction. Researchers study this pathway because its dysregulation is implicated in a wide range of human diseases, including cancer, immune dysfunction, and neurodegeneration. The dynamic phosphorylation of the inositol ring at positions 3, 4, and 5 generates distinct phosphoinositide species that act as membrane anchors and signaling platforms. Understanding the enzymes and regulatory mechanisms that control phosphatidylinositol metabolism is therefore essential for both basic cell biology and therapeutic development.
phosphatidylinositol metabolic process At A Glance
| GO ID | GO:0046488 |
|---|---|
| GO term | phosphatidylinositol metabolic process |
| Ontology | biological_process |
| Synonym | phosphatidylinositol metabolism; phosphoinositide metabolic process; phosphoinositide metabolism; PtdIns metabolic process; PtdIns metabolism |
| Major function | Synthesis, phosphorylation, and turnover of phosphatidylinositol and phosphoinositides for signaling and membrane trafficking |
| Key enzymes | Phosphatidylinositol kinases, phosphatases (e.g., myotubularins), phospholipases |
| Subcellular location | Membranes (plasma membrane, endosomes, nucleus) |
| Related pathways | Phosphoinositide signaling, membrane trafficking, nuclear lipid signaling |
What Is GO:0046488?
GO:0046488 phosphatidylinositol metabolic process is defined as the chemical reactions and pathways involving phosphatidylinositol, any glycophospholipid in which a sn-glycerol 3-phosphate residue is esterified to the 1-hydroxyl group of 1D-myo-inositol. This includes the synthesis, phosphorylation, dephosphorylation, and turnover of phosphatidylinositol and its phosphorylated derivatives, collectively known as phosphoinositides.
Why Is phosphatidylinositol metabolic process Important in Cell Biology?
Phosphatidylinositol metabolism is essential for cellular signal transduction, membrane dynamics, and organelle identity. The pathway generates phosphoinositides that recruit effector proteins to specific membranes, thereby controlling processes such as cell growth, survival, and immune responses. Dysregulation of this pathway contributes to cancer progression, autoimmune diseases, and neurological disorders. Moreover, recent studies have revealed that phosphoinositides and cholesterol regulate STING activation, linking lipid metabolism to innate immunity. Therefore, understanding phosphatidylinositol metabolism is critical for both fundamental cell biology and the development of targeted therapies.
• Regulates cell signaling through generation of phosphoinositide second messengers.
• Controls membrane trafficking and organelle identity.
• Modulates innate immune responses via STING activation.
• Implicated in cancer through altered phosphoinositide phosphatase activity.
• Involved in nuclear lipid signaling and gene expression.
• Myotubularin phosphatases regulate 3-phosphoinositide levels, affecting cell survival.
• Phosphoinositide synthesis pathways are conserved from plants to humans.
• Provides targets for therapeutic intervention in metabolic and immune disorders.
What Happens During phosphatidylinositol metabolic process?
Synthesis of phosphatidylinositol
In simple terms: The cell builds phosphatidylinositol by attaching a lipid tail to an inositol sugar.
Phosphatidylinositol is synthesized from CDP-diacylglycerol and myo-inositol by phosphatidylinositol synthase. This reaction forms the basic glycophospholipid that can be further phosphorylated. The synthesis occurs primarily in the endoplasmic reticulum and is essential for maintaining membrane lipid composition.
Phosphorylation to phosphoinositides
In simple terms: Enzymes add phosphate groups to the inositol ring, creating different signaling molecules.
Phosphatidylinositol can be phosphorylated at positions 3, 4, and 5 of the inositol ring by specific lipid kinases, generating phosphatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4-phosphate (PI4P), phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), and others. These phosphoinositides serve as docking sites for effector proteins and are key regulators of membrane trafficking and signaling.
Dephosphorylation by phosphatases
In simple terms: Phosphatases remove phosphate groups, reversing the actions of kinases.
Phosphoinositide phosphatases, such as myotubularins, specifically dephosphorylate 3-phosphoinositides, thereby terminating signals and recycling the lipids. The balance between kinase and phosphatase activities determines the steady-state levels of each phosphoinositide species.
Turnover and signaling
In simple terms: Phosphoinositides are constantly broken down and remade to transmit signals.
Phospholipases cleave phosphoinositides to produce soluble second messengers like inositol trisphosphate (IP3) and diacylglycerol (DAG), which propagate signals. This turnover is tightly regulated and is essential for processes such as calcium release and protein kinase C activation.
Nuclear phosphoinositide metabolism
In simple terms: The same lipids also exist inside the nucleus and control gene expression.
Nuclear phosphoinositides are involved in chromatin remodeling, transcription, and mRNA processing. They are generated by a distinct set of kinases and phosphatases within the nucleus, highlighting the compartmentalization of this pathway.
Key Genes Involved in GO:0046488 phosphatidylinositol metabolic process
The following genes encode key enzymes and regulators of phosphatidylinositol metabolism, including kinases, phosphatases, and phospholipases.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIK3CA | Phosphatidylinositol 3-kinase catalytic subunit alpha | Frequently mutated in cancer; generates PI(3,4,5)P3 |
| PIK3CB | Phosphatidylinositol 3-kinase catalytic subunit beta | Involved in signaling and cancer |
| PIK3CD | Phosphatidylinositol 3-kinase catalytic subunit delta | Immune cell signaling; target for immunomodulation |
| PIK3R1 | Phosphatidylinositol 3-kinase regulatory subunit alpha | Regulates PI3K activity; mutated in cancer |
| PTEN | Phosphatidylinositol 3-phosphatase | Tumor suppressor; dephosphorylates PI(3,4,5)P3 |
| MTM1 | Myotubularin 1 | Dephosphorylates PI3P and PI(3,5)P2; mutations cause myotubular myopathy |
| MTMR2 | Myotubularin related protein 2 | Regulates 3-phosphoinositides; linked to Charcot-Marie-Tooth disease |
| INPP4A | Inositol polyphosphate-4-phosphatase type I | Hydrolyzes PI(3,4)P2; tumor suppressor |
| INPP4B | Inositol polyphosphate-4-phosphatase type II | Regulates PI(3,4)P2 levels; implicated in cancer |
| PLCB1 | Phospholipase C beta 1 | Hydrolyzes PI(4,5)P2 to IP3 and DAG |
| PLCG1 | Phospholipase C gamma 1 | Key enzyme in phosphoinositide signaling downstream of RTKs |
| PIP5K1A | Phosphatidylinositol-4-phosphate 5-kinase type 1 alpha | Generates PI(4,5)P2 |
| PIP4K2A | Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha | Regulates PI(4,5)P2 synthesis |
| SACM1L | SAC1 like phosphatidylinositide phosphatase | Phosphatidylinositol phosphatase involved in Golgi function |
| FIG4 | FIG4 phosphoinositide 5-phosphatase | Regulates PI(3,5)P2; mutations cause neurodegeneration |
| VAC14 | VAC14 component of PIKFYVE complex | Scaffold for phosphoinositide synthesis |
| PIKFYVE | Phosphatidylinositol 3-phosphate 5-kinase | Synthesizes PI(3,5)P2; essential for endolysosomal function |
How Is phosphatidylinositol metabolic process Regulated?
Phosphatidylinositol metabolism is regulated at multiple levels. The activity of lipid kinases and phosphatases is controlled by upstream signals, including receptor tyrosine kinases and G-protein coupled receptors. Myotubularin phosphatases are regulated by protein-protein interactions and post-translational modifications, which determine their substrate specificity and subcellular localization. Additionally, the pathway is subject to feedback regulation by downstream effectors such as AKT, which can modulate PI3K activity. In the nucleus, phosphoinositide metabolism is regulated independently of the plasma membrane pool, with distinct enzymes and regulatory mechanisms. Recent studies have also shown that cholesterol levels can influence phosphoinositide-mediated STING activation, adding another layer of regulation.
phosphatidylinositol metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIK3CA | Cancer (breast, colorectal, lung) | Knock-in of activating mutations in cell lines |
| PTEN | Cancer (glioblastoma, prostate) | Knockout in cancer cell lines |
| MTM1 | X-linked myotubular myopathy | Knockout in muscle cells or animal models |
| FIG4 | Charcot-Marie-Tooth disease type 4J | Point mutation knock-in in neuronal cells |
| STING1 | Autoinflammatory diseases | Overexpression or knockout in immune cells |
Cancer
Alterations in phosphatidylinositol metabolism are common in cancer. Activating mutations in PIK3CA and loss of PTEN lead to elevated PI(3,4,5)P3 levels, promoting cell proliferation and survival. Phosphoinositide phosphatases such as INPP4B and MTMRs can act as tumor suppressors, and their dysregulation contributes to oncogenesis.
Neurological disorders
Mutations in myotubularin-related genes, including MTM1 and FIG4, cause severe neuromuscular diseases such as X-linked myotubular myopathy and Charcot-Marie-Tooth disease type 4J. These conditions highlight the importance of precise phosphoinositide regulation in neuronal function and muscle maintenance.
Immune dysfunction
Phosphoinositides regulate innate immune signaling through the STING pathway. Cholesterol and phosphoinositide interactions control STING activation, and dysregulation can lead to autoinflammatory diseases. Targeting phosphoinositide metabolism may offer therapeutic strategies for immune disorders.
From phosphatidylinositol metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PTEN alter phosphoinositide levels? | PTEN knockout cell line |
| How do cancer-associated PIK3CA mutations affect signaling? | PIK3CA point mutation knock-in |
| What is the role of MTM1 in muscle maintenance? | MTM1 knockout in myoblasts |
| Can we visualize phosphoinositide dynamics? | Tagged knock-in of lipid-binding domains |
| Does overexpression of PLCG1 enhance IP3 production? | PLCG1 overexpression cell line |
| Which genes regulate STING activation via phosphoinositides? | CRISPR library screening in immune cells |
How to Study the phosphatidylinositol metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS) | Quantitative levels of phosphoinositides | Profiling changes in knockout cells |
| Fluorescence microscopy | Subcellular localization of phosphoinositides | Live-cell imaging of signaling dynamics |
| CRISPR knockout screening | Gene essentiality for phosphoinositide pathways | Discovery of novel regulators |
| In vitro kinase assay | Enzymatic activity of lipid kinases | Characterization of PIK3CA mutants |
| Phosphatase assay | Enzymatic activity of lipid phosphatases | Studying MTM1 function |
| Co-immunoprecipitation | Protein-protein interactions | Identifying regulatory complexes |
| RNA-seq | Transcriptional changes | Assessing downstream effects of pathway modulation |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics allows quantitative profiling of phosphatidylinositol and its phosphorylated derivatives. This method can detect changes in lipid species following genetic or pharmacological perturbations.
Fluorescence imaging with biosensors
Genetically encoded biosensors, such as GFP-tagged PH domains, enable real-time visualization of specific phosphoinositides in live cells. This approach reveals spatiotemporal dynamics of phosphatidylinositol metabolism.
CRISPR screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate phosphatidylinositol metabolism or that are required for downstream signaling. Such screens are powerful for discovering novel regulators.
Biochemical assays
In vitro kinase and phosphatase assays using purified enzymes and lipid substrates measure catalytic activity and substrate specificity. These assays are essential for characterizing enzymes like myotubularins.
How CRISPR Can Be Used to Study GO:0046488 phosphatidylinositol metabolic process
Knockout
CRISPR knockout is used to completely ablate genes involved in phosphatidylinositol metabolism, such as PTEN or MTM1, to study their loss-of-function phenotypes. Knockout cell lines provide a clean background for biochemical and signaling assays.
Point Mutation
Point mutations, such as those found in PIK3CA in cancer, can be introduced using CRISPR base editing or homology-directed repair. These models help dissect the specific effects of disease-associated mutations on enzyme activity and downstream signaling.
Knock-in
Knock-in of tagged versions of enzymes or biosensor domains allows for real-time tracking of phosphoinositides and their interacting proteins. This approach is valuable for understanding spatiotemporal regulation.
Overexpression
Overexpression of wild-type or mutant enzymes, such as PLCG1 or PIK3CA, can amplify signaling pathways and reveal gain-of-function effects. Overexpression models are useful for studying downstream consequences of elevated phosphoinositide levels.
How EDITGENE Supports phosphatidylinositol metabolic process Research
Researchers studying phosphatidylinositol metabolic process-related genes often need to determine whether a candidate gene is causally involved in lipid signaling, membrane trafficking, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol metabolic process research.
Frequently Asked Questions About phosphatidylinositol metabolic process
What is phosphatidylinositol metabolic process?
It is the set of chemical reactions and pathways involving phosphatidylinositol, a glycophospholipid that serves as a precursor for signaling molecules.
What genes are involved in phosphatidylinositol metabolic process?
Key genes include PIK3CA, PTEN, MTM1, MTMR2, PLCB1, PLCG1, and PIKFYVE, among others.
How is phosphatidylinositol metabolism regulated?
It is regulated by the balance of lipid kinases and phosphatases, as well as upstream signals and subcellular localization.
What diseases are associated with phosphatidylinositol metabolic process?
Cancer, neurological disorders like myotubular myopathy, and immune dysfunction are linked to defects in this pathway.
What is the role of phosphoinositides in cell signaling?
Phosphoinositides act as membrane docking sites for effector proteins and are precursors of second messengers like IP3 and DAG.
How can I study phosphatidylinositol metabolism in the lab?
Methods include lipidomics, fluorescence imaging with biosensors, CRISPR screening, and biochemical enzyme assays.
What are myotubularin phosphatases?
They are a family of enzymes that specifically dephosphorylate 3-phosphoinositides, regulating their levels and downstream signaling.
How does phosphatidylinositol metabolism affect immunity?
Phosphoinositides and cholesterol regulate STING activation, which is critical for innate immune responses.
Can CRISPR be used to study phosphatidylinositol metabolism?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this pathway.
What is the connection between phosphatidylinositol metabolism and cancer?
Alterations in enzymes like PI3K and PTEN lead to abnormal phosphoinositide levels that drive cancer cell growth and survival.
Conclusion
GO:0046488 phosphatidylinositol metabolic process is a fundamental biological pathway that controls diverse cellular functions through the synthesis, phosphorylation, and turnover of phosphatidylinositol and its derivatives. Its dysregulation is implicated in cancer, neurological disorders, and immune diseases, making it a critical area of research. Advances in CRISPR-based models and analytical techniques continue to unravel the complexities of this pathway, offering new opportunities for therapeutic intervention.
References
- 1. Li J et al.. 2026. Regulation of STING activation by phosphoinositide and cholesterol.. Nature 652(8109):499-507 PMID: 41639452
- 3. Boss WF et al.. 2012. Phosphoinositide signaling.. Annu Rev Plant Biol 63:409-29 PMID: 22404474
- 4. Rudge SA et al.. 2016. Phosphatidylinositolphosphate phosphatase activities and cancer.. J Lipid Res 57(2):176-92 PMID: 26302980
- 6. Tolias KF et al.. 1999. Pathways for phosphoinositide synthesis.. Chem Phys Lipids 98(1-2):69-77 PMID: 10358929
- 7. Irvine RF. 2003. Nuclear lipid signalling.. Nat Rev Mol Cell Biol 4(5):349-60 PMID: 12728269
- 8. Robinson FL et al.. 2006. Myotubularin phosphatases: policing 3-phosphoinositides.. Trends Cell Biol 16(8):403-12 PMID: 16828287
